Richard W Bank MD
As President of the Beverly Hills consultancy BioVest Advisors LLC, Richard W. Bank, MD, 67, draws on decades of experience in the medical technology and financial investment fields. Dr. Bank obtained his MD from the Finch University of Health Sciences, The Chicago Medical School, subsequently completing residencies at New York’s Mount Sinai Medical Center and Baltimore’s Johns Hopkins School of Medicine. From 1980 to 1982, he held responsibilities as Chief of Gynecology at Beverly Hills Medical Center and Century City Doctors Hospital.
Richard W. Bank, MD, maintained Attending Physician responsibilities at Cedars-Sinai Medical Center in Los Angeles, from the early 1980s until 1995. He notably served as Medical Commissioner at the 1984 Los Angeles Summer Olympic Games. Dr. Bank has maintained faculty affiliation with the University of Southern California (USC) School of Medicine’s Department of Obstetrics and Gynecology for 30 years.
Richard W. Bank, MD, expanded into entrepreneurial activities in 1986, co-founding the medical firm USAT. The company’s at-home AIDS and HIV testing product achieved premarket approval from the FDA, but it did not reach the market due to USAT’s acquisition. In 1995, he founded First-Tier Biotechnology Partners, guiding the life science hedge fund until its 2004 purchase by Lehman Brothers Holdings, Inc.
Dr. Bank subsequently served in senior positions with the Lehman Brothers Holdings company Liberty View Health Sciences Fund (a division of Liberty View Capital Management). He also held a position as SBC Warburg Dillon Read’s Senior Equity Analyst and Director of Biotechnology, prior to its acquisition by UBS AG. Richard W. Bank, MD’s biotechnology consulting work over the past decade and a half has included engagements with Bradmer Pharmaceuticals, Inc., Athersys Pharmaceuticals, Inc., Guilford Pharmaceuticals, Inc., and Protein Design Labs, Inc. With Guilford Pharmaceuticals, Inc., Dr. Bank notably assisted in the development of a clinical protocol for treating patients with metastatic brain cancer.